4//SEC Filing
Walts Alan Edmund 4
Accession 0001415889-21-001851
CIK 0001035354other
Filed
Apr 1, 8:00 PM ET
Accepted
Apr 2, 9:04 PM ET
Size
8.7 KB
Accession
0001415889-21-001851
Insider Transaction Report
Form 4
Walts Alan Edmund
Director
Transactions
- Award
Restricted Stock Units
2021-04-01+37,695→ 37,695 total→ Common Stock (37,695 underlying) - Award
Stock Options (Right to Buy)
2021-04-01+40,000→ 40,000 totalExercise: $3.36Exp: 2031-04-01→ Common Stock (40,000 underlying)
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
- [F2]The restricted stock units were issued pursuant to the Issuer's 2018 Equity Incentive Plan. The restricted stock units will vest in full on December 1, 2021, subject to the Reporting Person's continued service with the Issuer, which vesting may be accelerated in connection with certain qualifying terminations of service or in connection with a corporate transaction. Promptly following vesting, and in any event on or prior to December 31, 2021, each restricted stock unit will be settled by delivery of one share of the Issuer's common stock to the Reporting Person.
- [F3]The stock options were issued pursuant to the Issuer's 2018 Equity Incentive Plan and vests as follows: one-half of the shares underlying the option shall vest on April 1, 2022 (the "Cliff Vesting Date"), the remainder of the grant shall vest in twelve (12) equal installments on each successive monthly anniversary of the Cliff Vesting Date, subject to Reporting Person's continuous service as of each such date.
Documents
Issuer
Eloxx Pharmaceuticals, Inc.
CIK 0001035354
Entity typeother
Related Parties
1- filerCIK 0001853544
Filing Metadata
- Form type
- 4
- Filed
- Apr 1, 8:00 PM ET
- Accepted
- Apr 2, 9:04 PM ET
- Size
- 8.7 KB